ADAM9 up-regulates N-cadherin via miR-218 suppression in lung adenocarcinoma cells

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Sher, Yuh Pyng ^a,b   Wang, Li Ju ^c   Chuang, Li Ling ^d   Tsai, Mong Hsun ^c   Kuo, Ting Ting ^a   Huang, Cheng Chung ^a   Chuang, Eric Y ^c   Lai, Liang Chuan ^c  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADAM9 PROTEIN; MEMBRANE PROTEIN; MICRORNA; MICRORNA 218; NERVE CELL ADHESION MOLECULE; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ADAM PROTEIN; ADAM9 PROTEIN, HUMAN; CADHERIN; CDH2 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN; MIRN218 MICRORNA, HUMAN;

ADAM9 GENE; ARTICLE; BRAIN METASTASIS; CARCINOMA CELL; CDH2 GENE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE CONTROL; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; LUNG ADENOCARCINOMA; MICROARRAY ANALYSIS; MORBIDITY; MORTALITY; NUCLEOTIDE SEQUENCE; UPREGULATION; WESTERN BLOTTING; 3' UNTRANSLATED REGION; ADENOCARCINOMA; BINDING SITE; CELL MOTION; CHEMISTRY; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; PATHOLOGY; RNA INTERFERENCE; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ADAM PROTEINS; ADENOCARCINOMA; ANTIGENS, CD; BASE SEQUENCE; BINDING SITES; CADHERINS; CELL LINE, TUMOR; CELL MOVEMENT; CLUSTER ANALYSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MEMBRANE PROTEINS; MICRORNAS; RNA INTERFERENCE; TRANSCRIPTIONAL ACTIVATION;

EID: 84899465786     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094065     Document Type: Article

References (54)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56: 106-130.
2. Wingo PA, Ries LA, Giovino GA, Miller DS, Rosenberg HM, et al. (1999) Annual report to the nation on the status of cancer, 1973-1996, with a special section on lung cancer and tobacco smoking. J Natl Cancer Inst 91: 675-690. (Pubitemid 29234561)
3. Hayama M, Chida M, Karube Y, Tamura M, Kobayashi S, et al. (2013) One-step Nucleic Acid Amplification for Detection of Lymph Node Metastasis in Lung Cancer. Ann Thorac Cardiovasc Surg.
4. Coleman RE (2006) Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin Cancer Res 12: 6243s-6249s.
5. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, et al. (2001) Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-analysis. BMC Cancer 1: 5.
6. Lee JM, Dedhar S, Kalluri R, Thompson EW (2006) The epithelial- mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol 172: 973-981.
7. Bonomi P (2002) Matrix metalloproteinases and matrix metalloproteinase inhibitors in lung cancer. Semin Oncol 29: 78-86.
8. Shintani Y, Higashiyama S, Ohta M, Hirabayashi H, Yamamoto S, et al. (2004) Overexpression of ADAM9 in non-small cell lung cancer correlates with brain metastasis. Cancer Res 64: 4190-4196. (Pubitemid 38802422)
9. Grinberg-Rashi H, Ofek E, Perelman M, Skarda J, Yaron P, et al. (2009) The expression of three genes in primary non-small cell lung cancer is associated with metastatic spread to the brain. Clin Cancer Res 15: 1755-1761.
10. Reid RA, Hemperly JJ (1990) Human N-cadherin: nucleotide and deduced amino acid sequence. Nucleic Acids Res 18: 5896. (Pubitemid 20343703)
11. Hulit J, Suyama K, Chung S, Keren R, Agiostratidou G, et al. (2007) N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation. Cancer Res 67: 3106-3116. (Pubitemid 46724847)
12. Nieman MT, Prudoff RS, Johnson KR, Wheelock MJ (1999) N-cadherin promotes motility in human breast cancer cells regardless of their E-cadherin expression. J Cell Biol 147: 631-644.
13. Yamashita S, Tsujino Y, Moriguchi K, Tatematsu M, Ushijima T (2006) Chemical genomic screening for methylation-silenced genes in gastric cancer cell lines using 5-aza-2′-deoxycytidine treatment and oligonucleotide microarray. Cancer Sci 97: 64-71. (Pubitemid 43257029)
14. Ng YH, Zhu H, Leung PC (2012) Twist modulates human trophoblastic cell invasion via regulation of N-cadherin. Endocrinology 153: 925-936.
15. Barbieri CE, Tang LJ, Brown KA, Pietenpol JA (2006) Loss of p63 leads to increased cell migration and up-regulation of genes involved in invasion and metastasis. Cancer Res 66: 7589-7597. (Pubitemid 44289215)
16. Dwyer MA, Joseph JD, Wade HE, Eaton ML, Kunder RS, et al. (2010) WNT11 expression is induced by estrogen-related receptor alpha and beta-catenin and acts in an autocrine manner to increase cancer cell migration. Cancer Res 70: 9298-9308.
17. Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, et al. (2013) The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 32: 491-501.
18. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854. (Pubitemid 24014542)
19. Monteys AM, Spengler RM, Wan J, Tecedor L, Lennox KA, et al. (2010) Structure and activity of putative intronic miRNA promoters. RNA 16: 495-505.
20. Lee Y, Kim M, Han J, Yeom KH, Lee S, et al. (2004) MicroRNA genes are transcribed by RNA polymerase II. EMBO J 23: 4051-4060. (Pubitemid 39472426)
21. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
22. Nath D, Slocombe PM, Webster A, Stephens PE, Docherty AJ, et al. (2000) Meltrin gamma(ADAM-9) mediates cellular adhesion through alpha(6)beta(1) integrin, leading to a marked induction of fibroblast cell motility. J Cell Sci 113 (Pt 12): 2319-2328. (Pubitemid 30426845)
23. Guaiquil V, Swendeman S, Yoshida T, Chavala S, Campochiaro PA, et al. (2009) ADAM9 is involved in pathological retinal neovascularization. Mol Cell Biol 29: 2694-2703.
24. Felli N, Felicetti F, Lustri AM, Errico MC, Bottero L, et al. (2013) miR-126&126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 8: e56824.
25. Chu YW, Yang PC, Yang SC, Shyu YC, Hendrix MJ, et al. (1997) Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. Am J Respir Cell Mol Biol 17: 353-360. (Pubitemid 127500840)
26. Sher YP, Tzeng TF, Kan SF, Hsu J, Xie X, et al. (2009) Cancer targeted gene therapy of BikDD inhibits orthotopic lung cancer growth and improves long-term survival. Oncogene 28: 3286-3295.
27. Brazma A, Hingamp P, Quackenbush J, Sherlock G, Spellman P, et al. (2001) Minimum information about a microarray experiment (MIAME)-toward standards for microarray data. Nat Genet 29: 365-371. (Pubitemid 34326681)
28. Pattyn F, Speleman F, De Paepe A, Vandesompele J (2003) RTPrimerDB: the real-time PCR primer and probe database. Nucleic Acids Res 31: 122-123. (Pubitemid 36150349)
29. Lu TP, Lee CY, Tsai MH, Chiu YC, Hsiao CK, et al. (2012) miRSystem: An Integrated System for Characterizing Enriched Functions and Pathways of MicroRNA Targets. PLoS One 7: e42390.
30. Kausar H, Munagala R, Bansal SS, Aqil F, Vadhanam MV, et al. (2013) Cucurbitacin B potently suppresses non-small-cell lung cancer growth: Identification of intracellular thiols as critical targets. Cancer Letters 332: 35-45.
31. Guan H, Wei G, Wu J, Fang D, Liao Z, et al. (2013) Down-regulation of miR-218-2 and its host gene SLIT3 cooperate to promote invasion and progression of thyroid cancer. J Clin Endocrinol Metab.
32. Tu Y, Gao X, Li G, Fu H, Cui D, et al. (2013) MicroRNA-218 Inhibits Glioma Invasion, Migration, Proliferation, and Cancer Stem-like Cell Self-Renewal by Targeting the Polycomb Group Gene Bmi1. Cancer Res.
33. Kinoshita T, Hanazawa T, Nohata N, Kikkawa N, Enokida H, et al. (2012) Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion through targeting laminin-332 in head and neck squamous cell carcinoma. Oncotarget 3: 1386-1400.
34. Alajez NM, Lenarduzzi M, Ito E, Hui AB, Shi W, et al. (2011) MiR-218 suppresses nasopharyngeal cancer progression through downregulation of survivin and the SLIT2-ROBO1 pathway. Cancer Res 71: 2381-2391.
35. Tie J, Pan Y, Zhao L, Wu K, Liu J, et al. (2010) MiR-218 inhibits invasion and metastasis of gastric cancer by targeting the Robo1 receptor. PLoS Genet 6: e1000879.
36. He X, Dong Y, Wu CW, Zhao Z, Ng SS, et al. (2012) MicroRNA-218 inhibits cell cycle progression and promotes apoptosis in colon cancer by downregulating BMI1 polycomb ring finger oncogene. Mol Med 18: 1491-1498.
37. Li J, Ping Z, Ning H (2012) MiR-218 Impairs Tumor Growth and Increases Chemo-Sensitivity to Cisplatin in Cervical Cancer. Int J Mol Sci 13: 16053-16064.
38. Wu DW, Cheng YW, Wang J, Chen CY, Lee H (2010) Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 70: 10392-10401.
39. Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang W, Jafferji M, et al. (2012) miR-218 directs a Wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J Biol Chem 287: 42084-42092.
40. He H, Di Y, Liang M, Yang F, Yao L, et al. (2013) The microRNA-218 and ROBO-1 signaling axis correlates with the lymphatic metastasis of pancreatic cancer. Oncol Rep 30: 651-658.
41. Small EM, Sutherland LB, Rajagopalan KN, Wang S, Olson EN (2010) MicroRNA-218 regulates vascular patterning by modulation of Slit-Robo signaling. Circ Res 107: 1336-1344.
42. Goossens K, Mestdagh P, Lefever S, Van Poucke M, Van Zeveren A, et al. (2013) Regulatory microRNA Network Identification in Bovine Blastocyst Development. Stem Cells Dev 22: 1907-1920.
43. Marlow R, Strickland P, Lee JS, Wu X, Pebenito M, et al. (2008) SLITs suppress tumor growth in vivo by silencing Sdf1/Cxcr4 within breast epithelium. Cancer Res 68: 7819-7827.
44. Dallol A, Da Silva NF, Viacava P, Minna JD, Bieche I, et al. (2002) SLIT2, a human homologue of the Drosophila Slit2 gene, has tumor suppressor activity and is frequently inactivated in lung and breast cancers. Cancer Res 62: 5874-5880. (Pubitemid 35204748)
45. Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, et al. (2010) MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS One 5: e12560.
46. Tseng RC, Lee SH, Hsu HS, Chen BH, Tsai WC, et al. (2010) SLIT2 attenuation during lung cancer progression deregulates beta-catenin and Ecadherin and associates with poor prognosis. Cancer Res 70: 543-551.
47. Chen WF, Gao WD, Li QL, Zhou PH, Xu MD, et al. (2013) SLIT2 inhibits cell migration in colorectal cancer through the AKT-GSK3beta signaling pathway. Int J Colorectal Dis 28: 933-940.
48. Vincent-Chong VK, Anwar A, Karen-Ng LP, Cheong SC, Yang YH, et al. (2013) Genome wide analysis of chromosomal alterations in oral squamous cell carcinomas revealed over expression of MGAM and ADAM9. PLoS One 8: e54705.
49. Micocci KC, Martin AC, Montenegro Cde F, Durante AC, Pouliot N, et al. (2013) ADAM9 silencing inhibits breast tumor cell invasion in vitro. Biochimie 95: 1371-1378.
50. Josson S, Anderson CS, Sung SY, Johnstone PA, Kubo H, et al. (2011) Inhibition of ADAM9 expression induces epithelial phenotypic alterations and sensitizes human prostate cancer cells to radiation and chemotherapy. Prostate 71: 232-240.
51. Fritzsche FR, Wassermann K, Jung M, Tolle A, Kristiansen I, et al. (2008) ADAM9 is highly expressed in renal cell cancer and is associated with tumour progression. BMC Cancer 8: 179.
52. Fry JL, Toker A (2010) Secreted and membrane-bound isoforms of protease ADAM9 have opposing effects on breast cancer cell migration. Cancer Res 70: 8187-8198.
53. Ramirez RD, Sheridan S, Girard L, Sato M, Kim Y, et al. (2004) Immortalization of human bronchial epithelial cells in the absence of viral oncoproteins. Cancer Res 64: 9027-9034. (Pubitemid 39665513)
54. Chen YJ, Huang WC, Wei YL, Hsu SC, Yuan P, et al. (2011) Elevated BCRP/ABCG2 expression confers acquired resistance to gefitinib in wild-type EGFR-expressing cells. PLoS One 6: e21428.